下丘脑外侧区注射TRH对大鼠胃酸分泌的影响

本文采用连续收集胃腔灌流法,观察下丘脑外侧区(LHA)注射促甲状腺激素释放激素(TRH)对大鼠胃酸分泌的影响,并分析TRH在LHA促进胃酸分泌的作用机制。结果表明:(1)LHA注射TRH(1μg)明显地刺激胃酸分泌;(2)预先向LHA注射酚妥拉明(10μg)、美多心安(5μg)及胃泌素抗体1μl(1:640)并不影响TRH的泌酸作用,如预先向LHA注射阿托品(5μg)则可消除TRH的泌酸效应;(3)垂体摘除及肾上腺切除均不影响TRH的泌酸作用;(4)隔下迷走神经切断后,LHA注入TRH的泌酸效应仍然出现,但持续时间显著缩短;腹腔交感神经节摘除后,TRH仍能促进胃酸分泌,但分泌量少而平稳。以上结果提示:LHA是TRH中枢泌酸效应的有关结构之一,其中枢机制是通过胆碱能M受体中介的,腹腔交感神经节和膈下迷走神经是TRH泌酸效应的传出途径。前者引起的泌酸反应出现较早且引起泌酸高峰,但持续时间短;后者则引起低平的持续分泌。     

中华白蛉的自育性研究

现场及实验室结果表明,我国黄土高原的大多数中华白蛉(Phlebotomus chinensis)应属自育性品系,它通常在羽化后、吸血前经交配能依靠腹节内脂肪体发育卵泡,一般在产卵后始行吸血。其生理性状是:胃内无血、腹节内有大量块状或条状脂肪体。羽化24小时后,附腺内有暗色颗粒,卵巢内有发育的卵泡。在25℃士1℃下它的生活史分快、慢两型。快型从卵至成虫仅需44—50夭,慢型需要以四龄幼虫滞育,其长短随滞育期而定,最长的滞育期达301天。观察了白蛉幼虫在饥饿状态下对自育性的影响。此外,还比较了吸血白蛉与自育性白蛉的妊卵数。吸血白蛉的妊卵数约较自育性的高出1/5。这种自育性品系的中华白蛉在自然居群约内占92%、主要栖于洞穴内为野栖种类。本文对自育性中华白蛉的生态及其防制策略作了分析和讨论。     

Cloning and expression in Escherichia coli of the gene encoding the structural subunit of Bacteroides nodosus fimbriae.

Bacteroides nodosus is the primary causative agent of ovine foot rot. Virulent isolates of this bacterium contain fimbriae which appear to play a major role in both infectivity and protective immunity. This paper presents the cloning and expression in Escherichia coli of the gene encoding the structural subunit of the fimbriae of B. nodosus. Total DNA was isolated from B. nodosus VCS 1001 (serogroup A), digested with HindIII, and inserted into the positive-selection vector pTR262. Recombinant E. coli clones were screened directly with anti-fimbrial antiserum by using a colony immunoassay. Several positive colonies were identified, each of which contained the same 5.5-kilobase HindIII insert. The prototype has been designated pBA101. Some clones also contained additional flanking sequences from the B. nodosus genome. Western transfer analyses verified that the positive clones were producing the B. nodosus fimbrial structural subunit, molecular weight ca. 17,500. The level of expression of the antigen in E. coli was comparable to that in B. nodosus itself and was unaffected by the insertion site or orientation of the cloned fragment, indicating that synthesis was being directed from an internal promoter. Restriction mapping and deletion analyses localized the fimbrial subunit gene to the vicinity of a PvuII site near the central region of the original HindIII insert. The expressed antigen was located in the membrane-cell wall fraction and may be exposed on the surface of the recombinant E. coli cells.     

Radioimmunoassay for quantitative determination of morphine in capsules of Papaver somniferum

A radioimmunoassay (RIA) procedure for the determination of pmol quantitites of morphine in capsule samples of Papaver somniferum was developed. An antiserum developed against a conjugate of morphine-3-hemisuccinate-BSA was relatively specific for morphine and possessed moderated cross-reactivity with codeine and mild cross-reactivity with thebaine, but none with narceine, papaverine, or noscapine. The standard curve was linear over a range of 0.01–0.20 ng. This assay allows for the rapid, sensitive and precise determination of morphine in unpurified aqueous extracts of capsule samples. The amounts of morphine in the aqueous extracts determined by radioimmunoassay were validated by high performance liquid chromatography (HPLC). The two methods show a high correlation coefficient (r = 0.98) with no significant difference in determinations of morphine content by RIA and HPLC.     

中国拟盘多毛孢属真菌的七个新组合

作者按照Steyaert(1949)和Sutton(1980)的分类观点,对1987—1988年从我国广西、江西、浙江等地采集的Pestalotiopsis属真菌进行了研究,确认了拟盘多毛孢属真菌的7个新组合种,即Pestalotiopsis carveri(Guba)comb nov.,Pestalotiopsis elasticae(Koord.)comb.nov.,Pestalotiopsis langloisii(Guba)comb.nov.,Pestalotiopsis oleandri(Guba)comb.nov.,Pestalotiopsis sinensis(shen)comb.nov.,Pestalotiopsis sydowiana(Bres.)comb.nov.和Pestalotiopsis zahlbruckneriana(Bres.)comb.nov.     

斜胸叶蝉属一新种（同翅目：叶蝉总科：耳叶蝉科）

本文记述耳叶蝉科斜胸叶蝉属一新种:黄缘斜胸叶蝉Epiclinata flavomarinata sp.nov.。标本采自我国西藏。文中描述了新种的外部形态及雄性外生殖器构造特征,并与近似种进行比较,附有主要特征图。模式标本保存于中国科学院动物研究所。     

Chaetomella acutiseta produces chaetomellic acids A and B which are reversible inhibitors of farnesyl-protien transferase

Chaetomellic acids A and B, isolated from Chaetomella acutiseta, are specific inhibitors of farnesyl-protein transferase that do not inhibit geranylgeranyl transferase type 1 or squalene synthase. Chaetomellic acids A and B are reversible inhibitors, resemble farnesyl diphosphate and probably inhibit FPTase by substituting for farnesyl diphosphate. Chaetomellic acid production appears to be widespread within the genus Chaetomella. Correspondence to: R. B. Lingham     

Management of raised blood pressure in New Zealand: a discussion document.

A report to the National Advisory Committee on Core Health and Disability Support Services, New Zealand, on the management of raised blood pressure recommends that decisions to treat raised blood pressure should be based primarily on the estimated absolute risk of cardiovascular disease rather than on blood pressure alone. In general, patients with a blood pressure of 150-170 mm Hg systolic or 90-100 mm Hg diastolic, or both, should be given treatment to lower blood pressure if the risk of a major cardiovascular disease event in 10 years is more than about 20%. The results of clinical trials indicate that, at this level of absolute risk, 150 people would require treatment to reduce the annual number of cardiovascular events by about one. Implementation of these recommendations may result in a smaller proportion of people aged under 60, particularly women, receiving treatment but an increased proportion of older people treated. In the absence of specific contraindications, low dose diuretics and low dose beta blockers should be considered for first line treatment, since for only these drug groups is there direct evidence of reduced risk of stroke and coronary disease in people with raised blood pressure.     

新型免疫抑制剂brasilicardin A的研究进展

Brasilicardin A (BraA)是从致病性放线菌巴西诺卡菌(Nocardia brasiliensis) IFM 0406中发现的具有显著免疫抑制作用(IC50=0.057μg/mL)的二萜糖苷类化合物。BraA发挥免疫抑制活性的作用机制与现有临床常用的免疫抑制剂不同,BraA通过抑制氨基酸转运体L系统的转运进而影响T-淋巴细胞对氨基酸的摄入而发挥免疫抑制作用。相比目前已知的免疫抑制剂环孢菌素A、子囊霉素和他克莫司等,BraA在小鼠混合淋巴细胞反应中显示低毒、高效的优势。因此,BraA作为新型的免疫抑制剂,极具开发潜力,已成为全球免疫抑制剂发现新领域。但其结构复杂、合成困难,原菌种产率低且具有致病性,BraA及其类似物的获得已成为此类新型免疫抑制剂研究的瓶颈。本文综述了BraA的分子特征、药理活性、作用机制、目前获得的BraA类似物和衍生化方面的研究进展,以期为BraA及其类似物的高效生产提供参考。